The aim of this article is to set out exactly what is expected of the audit team during a Medical Device Single Audit Program (MDSAP) audit. Each audit assesses how well a medical device company's quality management system (QMS) complies with the requirements issued by the five-member countries'(Australia, Brazil, Canada, Japan and the U.S.) regulatory authorities.
At the heart of MDSAP audit is a document referred to as “the model audit.” It acts as a roadmap for the auditors and establishes their mission. However, there is no reason why it can't also be used to build a QMS. The model audit allows the team to assess conformity with the requirements of the five regulatory authorities. It introduces a specific audit approach, and provides detailed methods for calculating how long the audits will take. The audit reports are sent to the five regulatory authorities. Each country maintains its own authority and has decided how the program can be incorporated into its own regulations.
MDSAP audits are based on the model audit, which includes the following criteria:
• Applicable regulatory requirements for the five countries
• Specific requirements from the five countries relating to:
The audit criteria are built into the model audit, which serves both as a reference document and a set of procedures.
There are four main processes:
And three support process:
The model audit provides the same structure for each of the seven processes:
To be awarded certification for the MDSAP program, manufacturers of medical devices need to hire an approved audit body (AB) to audit its QMS. ABs are entirely responsible for determining whether a manufacturer meets the requirements and for issuing certification documents. Each regulatory authority involved in MDSAP can use reports created by the ABs to support regulatory decisions within their own jurisdiction.
The following is a list of the ABs currently approved for MDSAP audits:
Enjoying this article? You may also enjoy this White Paper:
SO 13485: 2016 Part 1: Getting Ready for ChangesDownload Free White Paper
For more information and to contact the ABs, see the table published by the U.S. Food and Drug Administration (FDA).
The MDSAP program provides a certain level of transparency. It allows participating regulatory authorities to closely examine both the ABs and the manufacturers. ABs are assessed on a range of factors such as the code of conduct, impartiality and quality of special/unannounced audits, independence and ability of auditors, and training requirements.
Need guidance in meeting regulatory requirements? Don't hesitate to get in touch with us at www.apsalys.com.
Jean-Christophe Gourmanel is a business development engineer with over 20 years of experience in the pharmaceutical industry including working for one of the five largest pharmaceutical companies. He has held technical and management positions, acquiring solid experience in project management, sales processes, communications, quality management, and quality systems. Gourmanel developed and implemented a complete Six Sigma process at Janssen Cilag. In 2008, he founded and was CEO of a company that specialized in web technology business solutions for life science companies. Gourmanel then served at Straumann, a leading international dental implant company for six years as head of France key accounts, where he was involved with international topics, including Good Manufacturing Practice (GMP). He works currently as a sales manager and implementation project manager for MasterControl’s French partner Apsalys in life sciences strategic consulting and technical implementation solutions for French-speaking countries. Gourmanel is also a fan of scuba diving and spends his spare time in the beautiful area of Arcachon. He can be contacted at firstname.lastname@example.org
Tifany Desprez has joined Apsalys as its communication and marketing manager. She graduated in 2015 with a doctorate degree in neurosciences from the University of Bordeaux in France and worked as an assistant in communication at Bordeaux Neurocampus. Desprez continues to develop her interest in scientific innovation and information exchange in business access to life science organizations. She enjoys connecting with other life science industry professionals to gain insights about compliance and quality challenges. Desprez can be contacted at email@example.com.